Form 4: Aveanna CFO Sells Shares for Tax Obligations

Aveanna Healthcare Holdings' CFO, Matthew Buckhalter, sold common stock totaling 36,030 shares to cover tax liabilities from vested equity awards.

Summary

• Matthew Buckhalter, Chief Financial Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported the sale of common stock.
• The sales were conducted to satisfy tax obligations arising from the vesting of equity awards, as previously reported.
• A total of 36,030 shares were sold across three separate transactions between February 17, 2026, and February 19, 2026.
• On February 17, 2026, 9,351 shares were sold at a weighted average price of $7.6451 per share, with prices ranging from $7.47 to $7.97.
• On February 18, 2026, 13,167 shares were sold at a weighted average price of $7.3829 per share, with prices ranging from $7.175 to $7.53.
• On February 19, 2026, 13,512 shares were sold at a weighted average price of $7.2082 per share, with prices ranging from $7.06 to $7.29.
• Following these transactions, Mr. Buckhalter beneficially owns 529,243 shares of common stock.
• The transactions were part of aggregate sales managed by the company's stock plan administrator and were made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale of shares is a standard procedure for executives to cover tax liabilities upon the vesting of equity awards and does not indicate a change in management's outlook or confidence in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that tax-related sales of vested equity awards by executives are a common occurrence across all industries, particularly in companies that utilize equity compensation as a significant component of executive pay. These transactions are typically pre-arranged under Rule 10b5-1 plans to avoid accusations of trading on inside information.

Management Changes

Stakeholder Impact

• Shareholders: The sale of shares by the CFO for tax purposes is a routine event and is unlikely to have a significant direct impact on the company's operational performance or long-term strategy. It represents a minor dilution of ownership for tax purposes, which is common with equity compensation plans.

Key Dates

Recommendation

The reported transactions are routine tax-related sales by an insider under a Rule 10b5-1 plan. These sales do not reflect a discretionary decision by the CFO to reduce his stake due to a lack of confidence in the company's future. Therefore, this filing alone does not provide a basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate as it does not alter the fundamental investment thesis for Aveanna Healthcare Holdings.

Keywords

Aveanna Healthcare Holdings, AVAH, Form 4, Insider Trading, Stock Sale, CFO, Equity Awards, Tax Obligation, Rule 10b5-1